Literature DB >> 26901707

Efficacy of narrow band UVB in the treatment of cutaneous GvHD: an Indian experience.

L George1, D Peter1, M Chopra1, B George2, A Abraham2, V Mathews2, A Srivastava2, S A Pulimood1.   

Abstract

Mesh：

Year:  2016        PMID： 26901707     DOI： 10.1038/bmt.2016.13

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

1.  Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study.

Authors:  A Wiesmann; A Weller; G Lischka; T Klingebiel; L Kanz; H Einsele
Journal:  Bone Marrow Transplant       Date:  1999-01       Impact factor: 5.483

2.  Narrowband ultraviolet B phototherapy for the treatment of steroid-refractory and steroid-dependent acute graft-versus-host disease of the skin.

Authors:  Jonathan V Feldstein; Javier Bolaños-Meade; Viki L Anders; Rachel Abuav
Journal:  J Am Acad Dermatol       Date:  2011-05-25       Impact factor: 11.527

3.  Whole-body UVB irradiation during allogeneic hematopoietic cell transplantation is safe and decreases acute graft-versus-host disease.

Authors:  Marina Kreutz; Sigrid Karrer; Petra Hoffmann; Eva Gottfried; Rolf-Markus Szeimies; Joachim Hahn; Matthias Edinger; Michael Landthaler; Reinhard Andreesen; Miriam Merad; Ernst Holler
Journal:  J Invest Dermatol       Date:  2011-08-18       Impact factor: 8.551

4.  Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.

Authors:  Terry Furlong; Wendy Leisenring; Rainer Storb; Claudio Anasetti; Frederick R Appelbaum; Paul A Carpenter; H Joachim Deeg; Kristine Doney; Hans-Peter Kiem; Richard A Nash; Jean E Sanders; Robert Witherspoon; Dianne Thompson; Paul J Martin
Journal:  Biol Blood Marrow Transplant       Date:  2002       Impact factor: 5.742

5.  Narrowband ultraviolet B phototherapy ameliorates acute graft-versus-host disease by a mechanism involving in vivo expansion of CD4+CD25+Foxp3+ regulatory T cells.

Authors:  Satoshi Iyama; Kazuyuki Murase; Tsutomu Sato; Akari Hashimoto; Ayumi Tatekoshi; Hiroto Horiguchi; Yusuke Kamihara; Kaoru Ono; Shohei Kikuchi; Kohichi Takada; Yutaka Kawano; Tsuyoshi Hayashi; Koji Miyanishi; Yasushi Sato; Rishu Takimoto; Masayoshi Kobune; Satoru Mori; Junji Kato; Toshiharu Yamashita; Junji Kato
Journal:  Int J Hematol       Date:  2014-02-21       Impact factor: 2.490

6.  Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft-versus-host disease in oncohaematological paediatric patients.

Authors:  V Brazzelli; V Grasso; F Muzio; E Moggio; M Zecca; F Locatelli; G Borroni
Journal:  Br J Dermatol       Date:  2009-11-09       Impact factor: 9.302

Review 7.  Graft-versus-host disease.

Authors:  James L M Ferrara; John E Levine; Pavan Reddy; Ernst Holler
Journal:  Lancet       Date:  2009-03-11       Impact factor: 79.321

8.  PUVA therapy for chronic cutaneous graft-vs-host disease.

Authors:  R M Jampel; E R Farmer; G B Vogelsang; J Wingard; G W Santos; W L Morison
Journal:  Arch Dermatol       Date:  1991-11

Review 9.  1994 Consensus Conference on Acute GVHD Grading.

Authors:  D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483

10.  Phototherapy in the treatment of cutaneous graft-versus-host disease. Our preliminary experience in resistant patients.

Authors:  F Aubin; A Brion; E Deconinck; E Plouvier; P Hervé; P Humbert; J Y Cahn
Journal:  Transplantation       Date:  1995-01-15       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.